Boiardi A - Search Results

1

Antineuronal antibodies in patients with neuroblastoma: relationships with clinical features.

Salmaggi A, Luksch R, Forno MG, Pozzi A, Silvani A, Boiardi A, Gasparini M, Nemni R. Salmaggi A, et al. Among authors: boiardi a. Tumori. 1997 Nov-Dec;83(6):953-7. doi: 10.1177/030089169708300616. Tumori. 1997. PMID: 9526591

2

Effectiveness of early chemotherapy treatment in anaplastic astrocytoma patients.

Silvani A, Salmaggi A, Pozzi A, Fariselli L, Franzini A, Boiardi A. Silvani A, et al. Among authors: boiardi a. Tumori. 1995 Nov-Dec;81(6):424-8. doi: 10.1177/030089169508100607. Tumori. 1995. PMID: 8804468

3

Antineuronal antibody in a patient with neuroblastoma and opsoclonus-myoclonus-ataxia: a case report.

Salmaggi A, Nemni R, Pozzi A, Silvani A, Forno MG, Luksch R, Confalonieri P, Boiardi A. Salmaggi A, et al. Among authors: boiardi a. Tumori. 1997 May-Jun;83(3):709-11. doi: 10.1177/030089169708300316. Tumori. 1997. PMID: 9267493

4

Interstitial chemotherapy with mitoxantrone in recurrent malignant glioma: preliminary data.

Boiardi A, Salmaggi A, Pozzi A, Broggi G, Silvani A. Boiardi A, et al. J Neurooncol. 1996 Feb;27(2):157-62. doi: 10.1007/BF00177479. J Neurooncol. 1996. PMID: 8699238

5

Chemotherapy is effective as early treatment for primary central nervous system lymphoma.

Boiardi A, Silvani A, Pozzi A, Fariselli L, Broggi G, Salmaggi A. Boiardi A, et al. J Neurol. 1999 Jan;246(1):31-7. doi: 10.1007/s004150050302. J Neurol. 1999. PMID: 9987711

6

Locally delivered chemotherapy and repeated surgery can improve survival in glioblastoma patients.

Boiardi A, Eoli M, Pozzi A, Salmaggi A, Broggi G, Silvani A. Boiardi A, et al. Ital J Neurol Sci. 1999 Feb;20(1):43-8. doi: 10.1007/s100720050009. Ital J Neurol Sci. 1999. PMID: 10933484

7

Embryonal tumors in the adult population: implications in therapeutic planning.

Boiardi A, Silvani A, Eoli M, Fariselli L, Zappacosta B, Salmaggi A. Boiardi A, et al. Neurol Sci. 2000 Feb;21(1):23-30. doi: 10.1007/s100720070115. Neurol Sci. 2000. PMID: 10938199

8

CXCL12 expression is predictive of a shorter time to tumor progression in low-grade glioma: a single-institution study in 50 patients.

Salmaggi A, Gelati M, Pollo B, Marras C, Silvani A, Balestrini MR, Eoli M, Fariselli L, Broggi G, Boiardi A. Salmaggi A, et al. Among authors: boiardi a. J Neurooncol. 2005 Sep;74(3):287-93. doi: 10.1007/s11060-004-7327-y. J Neurooncol. 2005. PMID: 16132525

9

Phase II trial of cisplatin plus temozolomide, in recurrent and progressive malignant glioma patients.

Silvani A, Eoli M, Salmaggi A, Lamperti E, Maccagnano E, Broggi G, Boiardi A. Silvani A, et al. Among authors: boiardi a. J Neurooncol. 2004 Jan;66(1-2):203-8. doi: 10.1023/b:neon.0000013479.64348.69. J Neurooncol. 2004. PMID: 15015788 Clinical Trial.

10

Quality of life and brain tumors: what beyond the clinical burden?

Giovagnoli AR, Meneses RF, Silvani A, Milanesi I, Fariselli L, Salmaggi A, Boiardi A. Giovagnoli AR, et al. Among authors: boiardi a. J Neurol. 2014 May;261(5):894-904. doi: 10.1007/s00415-014-7273-3. Epub 2014 Mar 4. J Neurol. 2014. PMID: 24590402

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

149 results

Search Page

Filters